TREA

79109519 - VIVA|SCREEN

Follow

Information

  • Trademark
  • 79109519
  • Serial Number
    79109519
  • Registration Number
    4277773
  • Filing Date
    November 10, 2011
    13 years ago
  • Registration Date
    January 22, 2013
    11 years ago
  • Transaction Date
    June 05, 2022
    2 years ago
  • Status Date
    November 10, 2021
    3 years ago
  • Published for Opposition Date
    November 06, 2012
    12 years ago
  • Location Date
    January 22, 2013
    11 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    WIENER, MICHAEL A
  • Attorney Name
    BREWSTER TAYLOR
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
VIVA|SCREEN
Case File Statements
  • DM0000: The mark consists of one long term comprising the word "VIVA" in upper case letters followed by a vertical line and then the word "Screen" with an upper case letter "S" followed by lower case letters.
  • GS0091: Scientific apparatus and instruments, namely, typical equipment used in laboratories to take blood samples, to harvest biological cells, to select targeted cells, and microarrays chips for the identification and/or isolation of antibodies or the separation and recovery of cell clones producing antibodies in biological samples
  • GS0051: Prophylactic and therapeutic medicines and pharmaceutical products for the prevention, diagnosis and cure of diseases that induce an immune response; Prophylactic and therapeutic veterinary products for the prevention, diagnosis and cure of diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for medical or pharmaceutical purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for veterinary purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; micro-organisms; cells; cell lines; viruses; nucleotides; plasmids; DNA or RNA sequences; antibodies; cell clones producing antibodies; vectors for therapy and diagnostic for medical purposes; molecules and antibodies, all for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; biotechnological products for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; products for diagnosis for medical and pharmaceutical purposes, namely, proteins, antibodies, and products comprising these molecules for the diagnosis of diseases that induce an immune response; prophylactic or therapeutic vaccines
  • PM0001: VIVASCREEN
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Molecules obtained from biotechnologies, namely, proteins in raw material form for industrial use, scientific or medical research; biotechnological products for research and diagnosis, namely, chemicals, antibodies, antigens; micro-organisms, namely, cultures of microorganisms other than for medical and veterinary use; cells for scientific and laboratory uses; pre made and biological cell lines for scientific and laboratory uses; viruses for scientific and laboratory uses; nucleotides for use as biochemical reagents; plasmids for use as biochemical reagents; DNA or RNA sequences for use as biochemical reagents; antibodies for scientific and industrial research; cells for cloning for the production of antibodies; vectors for research and diagnosis; all of the previous products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary use
  • GS0421: Scientific services, namely, research and development of new products or process for production and/or purification of biological products for third parties; biological research; bacteriological, virology, immunology, biotechnology, genetic, medicine and pharmacology research; scientific research services for medical purposes; scientific research services for pharmaceutical purposes; scientific research services for veterinary purposes; development of new technologies for others in the field of biotechnology, biological and medical research; development of scientific and industrial research means inter alia to identify and isolate antibodies or cell clones producing antibodies
Case File Event Statements
  • 6/5/2022 - 2 years ago
    40 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 6/5/2022 - 2 years ago
    39 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 7/10/2020 - 4 years ago
    38 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 6/8/2020 - 4 years ago
    37 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 6/8/2020 - 4 years ago
    36 - INVALIDATION PROCESSED Type: INPC
  • 4/23/2020 - 4 years ago
    35 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 9/26/2019 - 5 years ago
    34 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/23/2019 - 5 years ago
    33 - CANCELLED SECTION 71 Type: C71T
  • 1/22/2018 - 6 years ago
    32 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 5/15/2017 - 7 years ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/28/2014 - 10 years ago
    30 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 5/14/2013 - 11 years ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 4/25/2013 - 11 years ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/25/2013 - 11 years ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/22/2013 - 11 years ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/2/2013 - 11 years ago
    25 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 1/22/2013 - 11 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/15/2012 - 11 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 11/6/2012 - 12 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/17/2012 - 12 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/17/2012 - 12 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/17/2012 - 12 years ago
    19 - NOTICE OF PUBLICATION Type: NPUB
  • 9/28/2012 - 12 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 9/21/2012 - 12 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/21/2012 - 12 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/21/2012 - 12 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/20/2012 - 12 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 9/19/2012 - 12 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/14/2012 - 12 years ago
    12 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 9/5/2012 - 12 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/27/2012 - 12 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/14/2012 - 12 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/22/2012 - 12 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/22/2012 - 12 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/22/2012 - 12 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/21/2012 - 12 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/20/2012 - 12 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/14/2012 - 12 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/14/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/13/2012 - 12 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR